Tecogen Inc. TGEN
3.05
0.03
0.99%
as of 25 Sep
- Market cap
- $91.2M
- P/E
- 0.0×
Follow TGEN
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
6.37 | 2.93 | 4.97 | 9.12 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(66.54) | (24.59) | (52.24) | (71.30) | |
P/B ratio |
8.92 | 3.91 | 6.27 | 10.03 | |
Price to Tangible BV |
10.92 | 4.71 | 7.44 | 12.24 | |
EV/Sales |
6.20 | 2.67 | 4.60 | 8.66 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(13.14) | (5.89) | (12.58) | (76.33) | |
EV/FCF |
(12.85) | (5.72) | (12.06) | (65.89) | |
Quick Ratio |
1.35 | 1.65 | 1.82 | 1.83 | |
Current Ratio |
2.93 | 3.02 | 3.12 | 2.71 | |
Net Debt/EBITDA |
3.10 | 4.42 | 4.13 | 7.66 | |
Debt/Assets |
3.13% | 3.15% | 2.68% | 2.25% | |
Debt/Equity |
0.06 | 0.06 | 0.05 | 0.04 | |
Asset Turnover |
0.82 | 0.81 | 0.80 | 0.81 | |
Operating CF/Net income |
1.10 | 1.47 | 0.64 | 1.67 | |
Capex/Depreciation |
(0.25) | (0.17) | (0.03) | (0.32) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.57% | 5.74% | 5.78% | 4.15% | |
Selling, General and Administrative Expense of Revenue |
69.63% | 68.81% | 87.93% | 55.47% | |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.09 | 0.11 | |
Share Based Compensation of Revenue |
2.54% | 2.08% | 2.60% | 1.76% | |
Graham Net Nets |
0.06 | 0.15 | 0.10 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.51%) | (12.89%) | (5.87%) | (2.38%) | |
Free Cash Flow Yield |
(7.57%) | (15.94%) | (7.68%) | (1.44%) | |
Revenue per Share |
0.19 | 0.21 | 0.20 | 0.25 | |
Operating CF per Share |
(0.08) | (0.10) | (0.09) | (0.12) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.08) | (0.11) | (0.10) | (0.13) | |
Cash per Share |
0.23 | 0.31 | 0.46 | 0.53 | |
Shareholders Equity per Share |
0.59 | 0.65 | 0.79 | 0.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.59 | 0.65 | 0.79 | 0.88 | |
Free Cash Flow |
(2.42) | (3.15) | (2.62) | (3.64) | |
Working Capital |
15.81 | 17.75 | 19.62 | 20.26 | |
Capital Expenditures |
(0.07) | (0.05) | (0.04) | (0.07) | |
Net Current Asset Value |
9.97 | 11.62 | 13.37 | 15.93 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(37.39%) | (33.47%) | (75.10%) | (29.67%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
5.55 | 5.59 | 5.42 | 6.47 | |
Average Payables |
4.01 | 3.98 | 3.76 | 4.13 | |
Average Inventory |
10.85 | 10.66 | 10.29 | 9.73 | |
Average Assets |
29.98 | 32.10 | 34.04 | 34.47 | |
Average Common Equity |
13.25 | 14.53 | 15.80 | 18.26 |
Columns are period end dates